26 Jul NexImmune
Kristi Jones, Pharm.D., CEO
Oct. 11 | 5:00pm | Oxford Biomedica Ballroom
NexImmune is a rapidly growing leader in the emerging field of antigen-directed immunotherapies. We are developing a novel technology that uses natural biology to orchestrate a targeted cell-mediated immune response across a broad range of diseases. We can customize our technology to intensify a targeted immune response to treat cancer or infectious disease. Conversely, we can also customize it to dampen an overactive immune response to treat autoimmune disorders.